Nkarta Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- September 05, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $114,000,000
Company Info
- Company Description
- Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.
- Market
- Cancer Therapy
- Location
- South San Francisco, California, USA
- Coinvestors
- Amgen Business Development, Deerfield Management Company, L.P., Life Sciences Partners, Logos Capital, NEA Ventures, Novo Holdings, RA Capital, Samsara BioCapital, SR One